Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

RRein Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
R

Rein Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
May 27, 2026VON RICKENBACH JOSEF HDirector4,500Common stock , $0.001 par value—Buy
May 26, 2026VON RICKENBACH JOSEF HDirector23,190Common stock , $0.001 par value—Buy
May 22, 2026VON RICKENBACH JOSEF HDirector15,950Common stock , $0.001 par value—Buy
May 21, 2026VON RICKENBACH JOSEF HDirector3,420Common stock , $0.001 par value—Buy
May 8, 2026WINDSOR JAMES BRIANSee Remarks150,000Stock Option (Right to Buy)—Grant / award
Apr 30, 2026WINDSOR JAMES BRIANSee Remarks25,000Common stock , $0.001 par value—Buy
Nov 14, 2025Voss Capital, LP10% Owner104,183Common Stock, $0.001 par value—Buy
Oct 28, 2025Voss Capital, LP10% Owner178,392Common Stock, $0.001 par value—Buy
Oct 27, 2025Voss Capital, LP10% Owner97,482Common Stock, $0.001 par value—Buy
Oct 24, 2025Voss Capital, LP10% Owner30,176Common Stock, $0.001 par value—Buy
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions